Revolutionizing Cancer Treatment
Academic Press Inc (Verlag)
978-0-443-41778-8 (ISBN)
- Noch nicht erschienen (ca. April 2026)
- Versandkostenfrei
- Auch auf Rechnung
- Artikel merken
Users will find flow charts, process diagrams, and case studies to facilitate understanding of complex concepts. The necessity for this book arises from the pressing demand for precision medicine in oncology, as conventional treatments often suffer from issues of specificity and efficacy. Ultimately, this work serves as a vital reference for students, researchers, and healthcare professionals dedicated to advancing cancer treatment through innovative drug delivery systems.
Dr. Bhupendra Gopalbhai Prajapati is a Professor (Research Cadre) at Parul Institute of Pharmacy, Parul University, Gujarat, India. He is also acting as Adjunct Professor at Department of Industrial Pharmacy, Faculty of Pharmacy, Silpakorn University, Thailand. With over 22 years of experience in academia, research, and industry, he specializes in lipid-based formulations, nano/microparticulate drug delivery, and bioavailability enhancement. A recipient of several prestigious awards including the AICTE Young Teacher Award and Ganpat University's Staff Excellence honors, Dr. Prajapati has published over 350 research/review papers, and has contributed to more than 170 book chapters. He actively mentors Ph.D. and PG scholars and serves as editor or section editor for several international publications in pharmaceutical sciences. Dr. Devesh U. Kapoor is Professor of Pharmaceutics at Dr. Dayaram Patel Pharmacy College, Bardoli, Gujarat, affiliated with Gujarat Technological University. He earned his Ph.D. in Pharmaceutical Sciences in 2013 and has over 20 years of academic experience. Dr. Kapoor has published 175+ research and review articles and contributed 50 book chapters. He is currently editing 18 international books with leading publishers and supervises four Ph.D. students in nanodrug delivery and modified release systems. His editorial roles include Associate Editor for Naunyn-Schmiedeberg’s Archives of Pharmacology, PLOS ONE, and several Frontiers journals, and Consulting Editor for Cytotechnology. He has reviewed manuscripts for 135+ journals and holds eight design patents. Dr. Kapoor has secured research and event grants from GUJCOST, GSBTM, and AICTE-ATAL, delivered 20+ invited talks, and actively participates in national conferences and workshops. . Dr. Anand Krishnan, Principal Investigator in Chemical Pathology, Office of the Dean, Faculty of Health Sciences, University of the Free State, South Africa. He leads the Precision Medicine Integrative Nano Diagnostics (P-MIND) laboratories, which focus on the biological functions of extracellular vesicles (EVs) in synthetic biology. His research encompasses cell surface protein modification, biomarker discovery through EVs derived from liquid biopsies, and the role of circulating biomarkers in disease development and stem cell biology. Dr. Krishnan has authored over 150 articles and edited eight books published by Elsevier, Springer, and Wiley. He received the National Research Foundation (NRF) rating for Next Generation Researchers in South Africa. In the latest list published by Stanford University, Dr. Krishnan was named among the Top 2% of the most influential scientists worldwide. He is an active member of the International Society of Extracellular Vesicles (ISEV), the African Organisation for Research and Training in Cancer (AORTIC), and the American Association of Cancer Research (AACR). Recently, he has been serving as an editor for the eLife journal, focusing on the Africa region. Rishabha Malviya, did his PhD (Pharmacy) work in the area of novel formulation development techniques. He has 12 years of research experience and presently works as an Associate Professor in the Department of Pharmacy, School of Medical and Allied Sciences, Galgotias University. His area of research interest includes formulation optimization, nano formulation, nanorobotic targeted drug delivery, localized drug delivery and characterization of natural polymers as pharmaceutical drugs. He has authored more than 200 research/review papers for national/international journals of repute. He has 51 patents and has received an Outstanding Reviewer award from Elsevier. He has authored/edited/editing more than 70 books (Wiley, CRC Press, Springer Nature, River Publishers, De Gryuter, IOP publishing, Nova Science Publishers and Apple Academic Press) and authored 125 book chapters. His name is included in the world's top 2% of scientists in 2020, 2021 and 2022 by Elsevier and Stanford University.
1. Introduction
2. Molecular imprinting techniques in the development of molecularly imprinted polymers-based drug delivery systems for cancer
3. Targeting Breast Cancer: Innovations with Molecularly Imprinted Polymers.
4. Targeting Prostate Cancer: Innovations with Molecularly Imprinted Polymers.
5. Targeting Pancreatic Cancer: Innovations with Molecularly Imprinted Polymers.
6. Targeting Lung Cancer: Innovations with Molecularly Imprinted Polymers.
7. Targeting Brain Cancer: Innovations with Molecularly Imprinted Polymers.
8. Targeting Ovarian Cancer: Innovations with Molecularly Imprinted Polymers.
9. Targeting Liver Cancer: Innovations with Molecularly Imprinted Polymers.
10. Targeting Cervical Cancer: Innovations with Molecularly Imprinted Polymers.
11. Targeting Colon Cancer: Innovations with Molecularly Imprinted Polymers.
12. Molecularly imprinted polymers as precision tools in cancer
| Erscheint lt. Verlag | 1.4.2026 |
|---|---|
| Verlagsort | San Diego |
| Sprache | englisch |
| Maße | 191 x 235 mm |
| Gewicht | 450 g |
| Themenwelt | Naturwissenschaften ► Biologie |
| ISBN-10 | 0-443-41778-4 / 0443417784 |
| ISBN-13 | 978-0-443-41778-8 / 9780443417788 |
| Zustand | Neuware |
| Informationen gemäß Produktsicherheitsverordnung (GPSR) | |
| Haben Sie eine Frage zum Produkt? |
aus dem Bereich
